FORTE BIOSCIENCES, INC. (FBRX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$24.60M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$22.44M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$18.38M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$11.58M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$24.60M | (m) | (m) | (m) | $0.00* | -$22.70M* | (m) | (m) | (m) | $193.00K |
| 2026-03-31 | Reported | (m) | -$22.44M | (m) | (m) | (m) | $0.00 | -$18.81M | (m) | (m) | (m) | $373.00K |
| 2025-09-30 | Reported | (m) | -$18.38M | (m) | (m) | (m) | $55.00K* | -$14.00M* | (m) | (m) | (m) | (m) |
| 2025-06-30 | Reported | (m) | -$11.58M | (m) | (m) | (m) | $0.00* | -$10.06M* | (m) | (m) | (m) | $0.00 |
| 2025-03-31 | Reported | (m) | -$16.12M | (m) | (m) | (m) | $61.00K | -$10.36M | (m) | (m) | (m) | $0.00 |
| 2024-09-30 | Reported | (m) | -$8.63M | (m) | (m) | (m) | $0.00* | -$8.13M* | (m) | (m) | (m) | (m) |
| 2024-06-30 | Reported | (m) | -$12.82M | (m) | (m) | (m) | $0.00* | -$5.94M* | (m) | (m) | (m) | (m) |
| 2024-03-31 | Reported | (m) | -$7.80M | (m) | (m) | (m) | $6.00K | -$6.67M | (m) | (m) | (m) | (m) |
| 2023-09-30 | Reported | (m) | -$10.22M | (m) | (m) | (m) | (m) | -$9.06M* | (m) | (m) | (m) | (m) |
| 2023-06-30 | Reported | (m) | -$9.03M | (m) | (m) | (m) | (m) | -$5.47M* | (m) | (m) | (m) | (m) |
| 2023-03-31 | Reported | (m) | -$6.86M | (m) | (m) | (m) | (m) | -$5.20M | (m) | (m) | (m) | (m) |
| 2022-09-30 | Reported | (m) | -$3.42M | (m) | (m) | (m) | (m) | -$1.94M* | (m) | (m) | (m) | (m) |
| 2022-06-30 | Reported | (m) | -$3.02M | (m) | (m) | (m) | (m) | -$1.38M* | (m) | (m) | (m) | (m) |
| 2022-03-31 | Reported | (m) | -$2.51M | (m) | (m) | (m) | (m) | -$1.98M | (m) | (m) | (m) | (m) |
| 2021-09-30 | Reported | (m) | -$7.70M | (m) | (m) | (m) | (m) | -$5.13M* | (m) | (m) | (m) | (m) |
| 2021-06-30 | Reported | (m) | -$5.75M | (m) | (m) | (m) | (m) | -$3.94M* | (m) | (m) | (m) | (m) |
| 2021-03-31 | Reported | (m) | -$4.74M | (m) | (m) | (m) | (m) | -$4.03M | (m) | (m) | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$5.01M | (m) | (m) | (m) | (m) | -$7.74M* | (m) | (m) | (m) | (m) |
| 2020-06-30 | Reported | (m) | -$34.75M | (m) | (m) | (m) | (m) | -$4.02M* | (m) | (m) | (m) | (m) |
| 2020-03-31 | Reported | (m) | -$2.03M | (m) | (m) | (m) | (m) | -$2.87M | (m) | $3.14M | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$684.00K | (m) | $9.00K | (m) | -$184.00K* | -$553.00K* | (m) | $13.29M | (m) | (m) |
| 2019-06-30 | Reported | (m) | -$629.00K | (m) | $9.00K | (m) | $124.00K* | $16.12M* | (m) | $11.97M | (m) | (m) |
| 2019-03-31 | Reported | (m) | -$16.87M | (m) | $9.00K | (m) | $133.00K | -$17.68M | (m) | $12.43M | (m) | (m) |
| 2018-09-30 | Reported | (m) | $1.43M | (m) | $18.01M | (m) | $619.00K* | $945.00K* | (m) | $12.26M | (m) | $1.51M |
| 2018-06-30 | Reported | (m) | -$15.33M | (m) | $9.00K | (m) | $657.00K* | -$10.76M* | (m) | $12.76M | (m) | (m) |
| 2018-03-31 | Reported | (m) | -$12.85M | (m) | $9.00K | (m) | $220.00K | -$12.71M | (m) | $10.44M | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$9.74M | (m) | $10.00K | (m) | $228.00K* | -$7.04M* | (m) | $7.56M | (m) | (m) |
| 2017-06-30 | Reported | (m) | -$8.65M | (m) | $10.00K | (m) | $56.00K* | (m) | (m) | $6.63M | (m) | (m) |
| 2017-03-31 | Reported | (m) | -$8.55M | (m) | (m) | (m) | $53.00K | (m) | (m) | $6.62M | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$8.53M | (m) | (m) | (m) | $351.00K* | (m) | (m) | $7.59M | (m) | (m) |
| 2016-06-30 | Reported | (m) | -$7.62M | (m) | (m) | (m) | $123.00K* | (m) | (m) | $6.53M | (m) | (m) |
| 2016-03-31 | Reported | (m) | -$7.57M | (m) | (m) | (m) | $41.00K | (m) | (m) | $6.47M | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$70.66M | (m) | (m) | (m) | $116.00K | -$50.88M | (m) | (m) | (m) | $1.04M |
| 2024-12-31 | Reported | (m) | -$36.60M | (m) | (m) | (m) | $37.00K | -$30.75M | (m) | (m) | (m) | $0.00 |
| 2023-12-31 | Reported | (m) | -$32.49M | (m) | (m) | (m) | $88.00K | -$28.71M | (m) | (m) | (m) | (m) |
| 2022-12-31 | Reported | (m) | -$13.90M | (m) | (m) | (m) | (m) | -$8.19M | (m) | (m) | (m) | (m) |
| 2021-12-31 | Reported | (m) | -$21.49M | (m) | (m) | (m) | (m) | -$16.68M | (m) | (m) | (m) | (m) |
| 2020-12-31 | Reported | (m) | -$46.28M | (m) | (m) | (m) | (m) | -$18.42M | (m) | (m) | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$4.06M | (m) | $36.00K | (m) | $162.00K | -$2.77M | (m) | $45.30M | (m) | $1.00K |
| 2018-12-31 | Reported | (m) | -$45.85M | (m) | $18.04M | (m) | $1.97M | -$34.47M | (m) | $51.08M | (m) | $1.70M |
| 2017-12-31 | Reported | (m) | -$37.63M | (m) | $41.00K | (m) | $655.00K | -$31.13M | (m) | $29.11M | (m) | $1.00K |
| 2016-12-31 | Reported | (m) | -$31.69M | (m) | $49.00K | (m) | $525.00K | -$29.54M | (m) | $27.22M | (m) | $1.00K |
| 2015-12-31 | Reported | (m) | -$22.95M | (m) | (m) | (m) | $231.00K | (m) | (m) | $19.17M | (m) | (m) |